Patents by Inventor Scott Michael Ulrich

Scott Michael Ulrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11608308
    Abstract: Aspects of the present disclosure include fatty acid ?-hydroxyester compounds (e.g., fatty acid esters of ?-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid ?-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: March 21, 2023
    Assignees: The J. David Gladstone Institutes, The Regents of The University Of California, Ithaca College
    Inventors: Eric Verdin, Scott Michael Ulrich, John C. Newman
  • Publication number: 20210171432
    Abstract: Aspects of the present disclosure include fatty acid ?-hydroxyester compounds (e.g., fatty acid esters of ?-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid ?-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
    Type: Application
    Filed: December 2, 2020
    Publication date: June 10, 2021
    Inventors: Eric Verdin, Scott Michael Ulrich, John C. Newman
  • Publication number: 20210094900
    Abstract: In various embodiments methods of preparing hydroxybutyryl 3-hydroxybutyrate and related compounds are provided along with methods of use thereof.
    Type: Application
    Filed: January 18, 2019
    Publication date: April 1, 2021
    Inventor: Scott Michael Ulrich
  • Patent number: 10889538
    Abstract: Aspects of the present disclosure include fatty acid ?-hydroxyester compounds (e.g., fatty acid esters of ?-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid ?-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: January 12, 2021
    Assignees: The J. David Gladstone Institutes, The Regents of The University Of California, Ithaca College
    Inventors: Eric Verdin, Scott Michael Ulrich, John C. Newman
  • Patent number: 10647658
    Abstract: Aspects of the present disclosure include fatty acid ?-hydroxyester compounds (e.g., fatty acid esters of ?-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid ?-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: May 12, 2020
    Assignees: The J. David Gladstone Institutes, The Regents of The University Of California, Ithaca College
    Inventors: Eric Verdin, Scott Michael Ulrich, John C. Newman
  • Patent number: 10562839
    Abstract: Aspects of the present disclosure include fatty acid ?-hydroxyester compounds (e.g., fatty acid esters of ?-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid ?-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: February 18, 2020
    Assignees: The J. David Gladstone Institutes, The Regents of The University Of California, Ithaca College
    Inventors: Eric Verdin, Scott Michael Ulrich, John C. Newman
  • Publication number: 20190382333
    Abstract: Aspects of the present disclosure include fatty acid ?-hydroxyester compounds (e.g., fatty acid esters of ?-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid ?-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
    Type: Application
    Filed: July 29, 2019
    Publication date: December 19, 2019
    Inventors: Eric Verdin, Scott Michael Ulrich, John C. Newman
  • Publication number: 20190359551
    Abstract: Aspects of the present disclosure include fatty acid ?-hydroxyester compounds (e.g., fatty acid esters of ?-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid ?-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
    Type: Application
    Filed: July 31, 2019
    Publication date: November 28, 2019
    Inventors: Eric Verdin, Scott Michael Ulrich, John C. Newman
  • Publication number: 20190248730
    Abstract: Aspects of the present disclosure include fatty acid ?-hydroxyester compounds (e.g., fatty acid esters of ?-hydroxybutyrate), fatty acid esters of butanediol, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions having one or more fatty acid ?-hydroxyester compounds and/or one or more fatty acid esters of butanediol. Methods for treating a subject by administering one or more esters to the subject are also provided. Kits containing one or more of the subject esters are also described.
    Type: Application
    Filed: June 2, 2017
    Publication date: August 15, 2019
    Applicants: THE J. DAVID GLADSTONE INSTITUTES, ITHACA COLLEGE, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, ITHACA COLLEGE
    Inventors: Eric Verdin, Scott Michael Ulrich, John C. Newman